11 new research advances from the past year
Over the past year, MD Anderson researchers and clinicians have investigated the gut microbiome, examined the earliest genesis of lung...
Advances in small cell lung cancer classification
Most patients with lung cancer have non-small cell lung cancer. However, around 15% of patients have a less-common type called small...
What is theranostics?
You may have heard the term theranostics when reading about cancer treatments, but what does it mean? The word theranostics is a...
Innovative directions in immunotherapy research
Immunotherapy is a cancer treatment that uses a patient’s immune system to target their cancer cells. Some common types of...
How are targeted therapies used in lung cancer treatment?
Lung cancer is the third-most common type of cancer and the most common cause of cancer-related deaths in the United States, according...
What’s new in leukemia research?
Leukemia is an overarching term encompassing several subtypes of blood cancers. Blood cells are produced in the bone marrow, the...
What are PARP inhibitors?
PARP inhibitors are a type of targeted therapy commonly used to treat breast cancer and ovarian cancer, among others. They target...